Drawing for RECALZA

USPTO serial 77061783

RECALZA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
CARL III, FRED
Law office
OFFICE OF TRADEMARK PROGRAM CONTROL

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RECALZA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael E. Mangelson

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, and bone metabolism disorders; pharmaceutical preparations for use in effecting analgesia and in pain managementABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 2, 2007MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Jun 30, 2007ABN1ABANDONMENT - EXPRESS MAILED—
Jun 30, 2007CORVREVIEW OF CORRESPONDENCE COMPLETE—
Jun 18, 2007EXARTEAS EXPRESS ABANDONMENT RECEIVED—
May 14, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 14, 2007ALIEASSIGNED TO LIE—
Apr 26, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 17, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Apr 17, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 17, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 4, 2007DOCKASSIGNED TO EXAMINER—
Dec 14, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance